Imaging Contrast

Contrast agents are injected into patients to help enhance images to make it easier for radiologists distinguish specific areas of the body from surrounding tissues. The most commonly used agents are iodinated contrast dye for computed tomography (CT), interventional cath lab angiography,  RF fluoroscopy, and in surgical OR procedures. MRI scans typically use gadolinium-based contrast agents. Ultrasound and echocardiography (cardiac ultrasound) imaging use contrast agents composed of microscopic bubbles to enhance images that otherwise would be suboptimal.

RSS icon
A comparison between a traditional iodine contrast angiogram (left), and a gadolinium contrast angiogram (right). MRI gadolinium contrast is starting to be used in some interventional radiology procedures and is being considered in interventional cardiology due to the iodine contrast shortage.

Gadolinium can be used as substitute for iodine contrast in some interventional imaging procedures

Gadolinium might be an alternative, stop-gap solution for interventional procedures during the current iodine contrast shortage.

May 23, 2022
The imaging iodine contrast shortage is delaying procedures and causing rationing at hospitals. impact is it having on hospitals and the tough decisions that are being made to triage patients to determine if they will get a contrast CT scan or an interventional or surgical procedure requiring contrast. Photo by Dave Fornell

VIDEO: Imaging contrast shortage is delaying procedures and causing rationing

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the American College of Radiology Board of Chancellors, explains the contrast shortage situation and the tough decisions providers are being forced to make.

May 23, 2022
Alan Matsumoto explains gadolinium as substitute for iodine contrast during shortage

VIDEO: Gadolinium being substituted for iodine contrast in some procedures due to shortage

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia, vice chair of the American College of Radiology (ACR) Board of Chancellors, and chairman of the ACR Commission on Interventional and Cardiovascular Radiology, explains that the iodine contrast shortage has led to use of MRI gadolinium contrast agents in some cases.

May 20, 2022
Kirk Garratt, past SCAI president, explains the impact of the iodine contrast shortage on interventional cardiology and the cath lab. #SCAI

VIDEO: How the iodine contrast shortage is impacting interventional cath labs

Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.

May 19, 2022
A medical professional trained to manage contrast reactions should be on-site at any imaging facilities doing contrast studies to maintain patient safety, according to a an updated statement from the American College of Radiology. The ACR has released the latest edition of the ACR Appropriateness Criteria, which includes 221 diagnostic imaging and interventional radiology topics with more than 1,050 clinical variants covering 2,900 clinical scenarios. #ACR #AUC #appropriateuse

Addressing contrast media shortage in the short, mid and long term

“We need to commit to changing the supply chain so that a single event in a faraway country does not put us in this predicament again," experts wrote in a new special report shared by Radiology.

May 19, 2022
With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have eluded that conservation efforts are of critical importance.#contrastshortage #CTcontrast #iodinatedcontrast

GE provides update on contrast media shortage

The COVID lockdowns at the Shanghai plant began on March 31, and although the plant there has since resumed operations, they are not yet at 100% capacity.

May 18, 2022
With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have eluded that conservation efforts are of critical importance.#contrastshortage #CTcontrast #iodinatedcontrast

Preserving contrast media supplies: 7 ACR recommendations

With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have alluded that conservation efforts are of critical importance.

May 9, 2022

Be prepared: IV contrast media shortage could last up to 8 weeks

All formulations and concentrations of GE Healthcare’s Omnipaque (iohexol) are expected to be in short supply until mid-June due to COVID lockdowns where the contrast is manufactured.

May 6, 2022
Displaying 65 - 72 of 131

Around the web

Cardiovascular Business
AI improves CT assessments, boosts care for real-world heart patients

Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.

Cardiovascular Business
AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required

Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans. 

Radiology Business
Google teams with Bayer to address radiologist burnout via AI

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup